“…For instance, Kantevari and co-workers 4 tested different derivatives of 2-aryl-7,8-dihydroquinolin-5(6 H )-ones against Mycobacterium tuberculosis strain H37Rv, with compound 1 being the most potent with a MIC of 1.56 μg/mL. Valderrama and co-workers 5 tested different 2-aryl-7,8-dihydroquinolin-5(6 H )-ones bearing quinones, such as 2 , as antitumor agents, whereas Dhara and co-workers 6 synthesized 2-aryl-7,8-dihydroquinolin-5(6 H )-ones, such as 3 , that were proven to be cytotoxic in different cell lines. Also, this moiety can be derivatized into other compounds, as reported by Kantevari and co-workers, 7 in which they synthesized miscellaneous 2-aryl-7,8-dihydroquinolin-5(6 H )-ylidenehydrazinecarbothioamides, such as 4 , and it was determined to be more potent as antitubercular than the parent 2-aryl-7,8-dihydroquinolin-5(6 H )-one derivative (Figure 1 ).…”